iih and glp 1 Infographic: Landmark trials in Neuro-Ophthalmology—results of the phase II Idiopathic Intracranial Hypertension Pressure Trial GLP-1 Agonists May Help Reduce

This concept is well established in other fields, such as rheumatoid arthritis (RA) and multiple sclerosis (MS), which have robust biomarkers of disease progressionX-ray imaging and inflammatory markers (e.g

However, they must be given by a medical professional and may carry more risks

Using a machine learning-assisted Genetic Risk Score (GRS), researchers analysed the relationship between individual genetic profiles and adverse events, including nausea

That makes medical supervision important before and during treatment

Its crucial to discuss any pre-existing conditions with a healthcare provider before starting a GLP-1 receptor agonist, as they can help determine the most appropriate treatment based on individual risk factors